Historical shareholding details of Vanguard Tax-Managed Capital App Fund holdings in Neurocrine Biosciences, Inc. (NBIX)

Monthly changes of Vanguard Tax-Managed Capital App Fund shareholding in Neurocrine Biosciences, Inc. over the previous months

Month Name Total no. shares held Percent Holding
Jul 31, 2025 Vanguard Tax-Managed Capital App Fund 40,804 0.04%
Jun 30, 2025 Vanguard Tax-Managed Capital App Fund 40,804 0.04%
May 31, 2025 Vanguard Tax-Managed Capital App Fund 40,804 0.04%
Apr 30, 2025 Vanguard Tax-Managed Capital App Fund 40,804 0.04%
Mar 31, 2025 Vanguard Tax-Managed Capital App Fund 40,804 0.04%
Feb 28, 2025 Vanguard Tax-Managed Capital App Fund 40,804 0.04%
Jan 31, 2025 Vanguard Tax-Managed Capital App Fund 40,804 0.04%
Dec 31, 2024 Vanguard Tax-Managed Capital App Fund 40,804 0.04%
Nov 30, 2024 Vanguard Tax-Managed Capital App Fund 32,932 0.03%
Oct 31, 2024 Vanguard Tax-Managed Capital App Fund 32,932 0.03%
Sep 30, 2024 Vanguard Tax-Managed Capital App Fund 32,932 0.03%
Aug 31, 2024 Vanguard Tax-Managed Capital App Fund 32,932 0.03%
Jul 31, 2024 Vanguard Tax-Managed Capital App Fund 32,932 0.03%
Jun 30, 2024 Vanguard Tax-Managed Capital App Fund 32,932 0.03%
May 31, 2024 Vanguard Tax-Managed Capital App Fund 36,922 0.04%
Apr 30, 2024 Vanguard Tax-Managed Capital App Fund 32,932 0.03%
Mar 31, 2024 Vanguard Tax-Managed Capital App Fund 32,932 0.03%
Feb 29, 2024 Vanguard Tax-Managed Capital App Fund 32,932 0.03%
Jan 31, 2024 Vanguard Tax-Managed Capital App Fund 32,932 0.03%
Dec 31, 2023 Vanguard Tax-Managed Capital App Fund 32,932 0.03%
Nov 30, 2023 Vanguard Tax-Managed Capital App Fund 32,932 0.03%
Oct 31, 2023 Vanguard Tax-Managed Capital App Fund 32,932 0.03%
Sep 30, 2023 Vanguard Tax-Managed Capital App Fund 29,271 0.03%
Aug 31, 2023 Vanguard Tax-Managed Capital App Fund 29,271 0.03%
Jul 31, 2023 Vanguard Tax-Managed Capital App Fund 29,271 0.03%
Jun 30, 2023 Vanguard Tax-Managed Capital App Fund 29,271 0.03%
May 31, 2023 Vanguard Tax-Managed Capital App Fund 29,271 0.03%
Apr 30, 2023 Vanguard Tax-Managed Capital App Fund 29,271 0.03%

View all ownership details of Neurocrine Biosciences, Inc.